Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies

NewsGuard 100/100 Score

Medtronic, Inc. (NYSE: MDT), today announced the launch of the TSRH® 3Dx Spinal System. Designed with procedural efficiency in mind, the TSRH 3Dx Spinal System offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA®) Screw option provides surgeons a variable angle posted screw for targeted, controlled correction maneuvers. The OSTEOGRIP® Screw enhances bone fixation by incorporating a dual-lead thread pattern that reduces toggle at the bone-screw interface.

Building on more than 20 years of clinical success, this next generation pedicle screw system includes competitive differentiating technology for addressing multiple spinal pathologies, from degenerative disc disease to spinal deformity. The system also offers CHROMALOY™ rods and a minimally invasive capability.

“The TSRH 3Dx Spinal System allows me to better match solutions to specific patient needs,” said Dr. Brett Scott. “It gives me confidence by marrying new technologies with a long clinical history of success.”

In 1987, Medtronic’s collaboration with the Texas Scottish Rite Hospital for Children in Dallas, Texas, to develop a system to treat scoliosis, led to the development of the TSRH Spinal System – a hook, rod, and screw system used in complex spinal procedures. Since then, the TSRH System has evolved into one of the most popular spinal systems on the market.

For the approximately 268,000 people who suffer degenerative spinal conditions, deformity, or injury of the thoracic, lumbar, and sacral spine, the TSRH 3Dx Spinal System offers an alternative for spinal stabilization with fusion.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing osteosarcoma prognosis with AI-assisted tumor cell density analysis